Blonanserin-induced Mood Alteration in Schizophrenia and Schizoaffective Disorder: Two Cases
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Min, Aran | - |
dc.contributor.author | Kim, Daeho | - |
dc.date.accessioned | 2022-07-16T07:08:29Z | - |
dc.date.available | 2022-07-16T07:08:29Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2013-12 | - |
dc.identifier.issn | 1738-1088 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/161326 | - |
dc.description.abstract | We report two outpatients, one with schizophrenia and one with schizoaffective disorder, who developed manic or hypomanic episodes following the initiation of blonanserin during the course of treatment. Blonanserin is a novel antipsychotic that acts as a 5-HT and D2 receptor antagonist. Both patients developed hypomanic episodes within 2 weeks of receiving a small dose (6-8 mg) of blonanserin, and one patient later developed full-blown mania; both episodes ended within 1 rrionth of discontinuing blonanserin, The mood alteration observed in these cases suggests a possible antidepressant effect of blonanserin; thus, clinicians should monitor mood changes when administering this antipsychotic. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN COLL NEUROPSYCHOPHARMACOLOGY | - |
dc.title | Blonanserin-induced Mood Alteration in Schizophrenia and Schizoaffective Disorder: Two Cases | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Daeho | - |
dc.identifier.doi | 10.9758/cpn.2013.11.3.165 | - |
dc.identifier.scopusid | 2-s2.0-84892406809 | - |
dc.identifier.wosid | 000342855500009 | - |
dc.identifier.bibliographicCitation | CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, v.11, no.3, pp.165 - 167 | - |
dc.relation.isPartOf | CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE | - |
dc.citation.title | CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE | - |
dc.citation.volume | 11 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 165 | - |
dc.citation.endPage | 167 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001825744 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.description.journalRegisteredClass | other | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | ATYPICAL ANTIPSYCHOTICS | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | MANIA | - |
dc.subject.keywordAuthor | Blonanserin | - |
dc.subject.keywordAuthor | Bipolar disorder | - |
dc.subject.keywordAuthor | Antipsychotic agents | - |
dc.subject.keywordAuthor | Schizophrenia | - |
dc.subject.keywordAuthor | Psychotic disorders | - |
dc.identifier.url | https://www.cpn.or.kr/journal/view.html?doi=10.9758/cpn.2013.11.3.165 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.